Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 04, 2025

Get In Touch

Eli Lilly Omvoh secures USFDA approval as single-injection maintenance regimen in adults with ulcerative colitis Pharma News

Eli Lilly Omvoh secures USFDA approval as single-injection maintenance regimen in adults with ulcerative colitis

  • 28 October 2025
  • 6 days ago

Lilly to buy Adverum Biotechnologies Pharma News

Lilly to buy Adverum Biotechnologies

  • 26 October 2025
  • 1 week ago

Eli Lilly's Diabetes Drug Mounjaro Gets Second Brand Yurpeak via Cipla Deal Pharma News

Eli Lilly's Diabetes Drug Mounjaro Gets Second Brand Yurpeak via Cipla Deal

  • 24 October 2025
  • 1 week ago

CDSCO Panel Clears Eli Lilly's Tirzepatide for Phase IV Clinical Trial in India Pharma News

CDSCO Panel Clears Eli Lilly's Tirzepatide for Phase IV Clinical Trial in India

  • 21 October 2025
  • 1 week ago

Roche gets USFDA clearance for Elecsys pTau181 test for Alzheimer's disease Pharma News

Roche gets USFDA clearance for Elecsys pTau181 test for Alzheimer's disease

  • 15 October 2025
  • 2 weeks ago

Gates Foundation, PAHO Push to Make Mounjaro, Wegovy Affordable in Low-Income Countries Pharma News

Gates Foundation, PAHO Push to Make Mounjaro, Wegovy Affordable in Low-Income Countries

  • 10 October 2025
  • 3 weeks ago

Rs 233 Crore in 6 Months: Mounjaro Becomes India's Second-Biggest Drug by Sales Pharma News

Rs 233 Crore in 6 Months: Mounjaro Becomes India's Second-Biggest Drug by Sales

  • 10 October 2025
  • 3 weeks ago

Eli Lilly Kisunla gets marketing authorization from European Commission for early symptomatic Alzheimer's disease Pharma News

Eli Lilly Kisunla gets marketing authorization from European Commission for early symptomatic Alzheimer's disease

  • 28 September 2025
  • 1 month ago

Eli Lilly Inluriyo gets USFDA nod for adults with advanced breast cancer Pharma News

Eli Lilly Inluriyo gets USFDA nod for adults with advanced breast cancer

  • 26 September 2025
  • 1 month ago

Eli lilly, Circle Pharma ink pact to further enhance AI/ML capabilities Oncology

Eli lilly, Circle Pharma ink pact to further enhance AI/ML capabilities

  • 09 September 2025
  • 1 month ago

Recent News

Nanotechnology Reverses Alzheimer's Symptoms in Mi...

  • 03 November, 2025

Gum disease could silently cause serious brain dam...

  • 03 November, 2025

Can Early-Day Fasting Significantly Boost Metaboli...

  • 03 November, 2025

Delhi HC bars doctor from running medical centre d...

  • 03 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.